Items where the Publication is Alimentary pharmacology & therapeutics

Number of items: 11.
Article
  • Predicting the advent of ascites and other complications in primary biliary cirrhosis: a staged model approach. (2010) Chan, C-W; Tsochatzis, EA; Carpenter, JR; Rigamonti, C; Gunsar, F; Burroughs, AK
  • Long-term ursodeoxycholic acid therapy for primary biliary cirrhosis: a follow-up to 12 years. (2005) Chan, CW; Gunsar, F; Feudjo, M; Rigamonti, C; Vlachogiannakos, J; Carpenter, JR; Burroughs, AK
  • Abnormal liver tests in people aged 75 and above: prevalence and association with mortality. (2011) Fleming, KM; West, J; Aithal, GP; Fletcher, AE
  • Predictors of gastroduodenal erosions in patients taking low-dose aspirin. (2010) Hart, J; Hawkey, CJ; Lanas, A; Naesdal, J; Talley, NJ; Thomson, ABR; Yeomans, ND
  • Commentary: how long does one need to fast before a Fibroscan examination? Authors' reply. (2013) Lemoine, M; Shimakawa, Y; Nayagam, S; Njie, R; Thursz, M
  • Food intake increases liver stiffness measurements and hampers reliable values in patients with chronic hepatitis B and healthy controls: the PROLIFICA experience in The Gambia. (2013) Lemoine, M; Shimakawa, Y; Njie, R; Njai, HF; Nayagam, S; Khalil, M; Goldin, R; Ingiliz, P; Taal, M; Nyan, O; Corrah, T; D'Alessandro, U; Thursz, M
  • Small intestinal cancer in England & Wales and Scotland: time trends in incidence, mortality and survival. (2006) Shack, LG; Wood, HE; Kang, JY; Brewster, DH; Quinn, MJ; Maxwell, JD; Majeed, A
  • Increased proportion of CD16(+) NK cells in the colonic lamina propria of inflammatory bowel disease patients, but not after azathioprine treatment. (2011) Steel, AW; Mela, CM; Lindsay, JO; Gazzard, BG; Goodier, MR
  • Does concurrent prescription of selective serotonin reuptake inhibitors and non-steroidal anti-inflammatory drugs substantially increase the risk of upper gastrointestinal bleeding? (2005) Tata, LJ; Fortun, PJ; Hubbard, RB; Smeeth, L; Hawkey, CJ; Smith, CJP; Whitaker, HJ; Farrington, CP; Card, TR; West, J
  • Clinical trial: a multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double-blind placebo-controlled study. (2009) WILLIAMS, EA; STIMPSON, J; WANG, D; PLUMMER, S; GARAIOVA, I; BARKER, ME; CORFE, BM
  • Effects of rabeprazole, 20 mg, or esomeprazole, 20 mg, on 24-h intragastric pH and serum gastrin in healthy subjects. (2002) Warrington, S; Baisley, K; Boyce, M; Tejura, B; Morocutti, A; Miller, N